A study is reporting successful clinical trial results for a new orally administered iteration in a novel class of drugs designed to treat migraine, ahead of a potential FDA approval later this year. But some scientists are questioning how clinically useful these new migraine drugs actually are.
Continue Reading
For some migraine sufferers, the pain is preceded by visual artefacts called aura, triggered by a wave of electrical activity in the brain. Now researchers have found a way to counter and slow the spread of those signals, which could be the first step towards preventing or lessening migraines.
Continue Reading
After successful and safe clinical trials, the FDA has approved a first-of-its-kind migraine preventative medicine. It's the first in an entirely new class of drugs designed to block the activity of a specific peptide known to activate migraines that has been cleared for public use by the agency.
Continue Reading
A new antibody treatment developed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results, raising hopes of a possible revolution on the horizon for sufferers of this debilitating condition.
Continue Reading
There may be new hope for migraine sufferers, in the form of a gadget that gets shoved up the ear. It alternately heats and cools the inside of the ear canal, and was recently shown to be effective in a study carried out by Britain's University of Kent.
Continue Reading
In recent years we've seen devices such as headbands that are designed to treat migraines. One of the latest such gadgets – which is worn on the arm like a blood pressure cuff – was recently the subject of a promising study.
Continue Reading
See the stories that matter in your inbox every morning